26.74
Greenwich Lifesciences Inc Azioni (GLSI) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
|
|
3.18%
4.1746
|
4.046 | 3.2823 | 8.0842 | 2.7291 |
| Operating Income/Loss |
3.18%
-4.1746
|
-4.046 | -3.2823 | -8.0842 | -2.7291 |
| Income/Loss From Continuing Operations Before Tax |
3.14%
-4.1518
|
-4.0253 | -3.2584 | -8.0402 | -2.6687 |
| Income/Loss From Continuing Operations After Tax |
3.14%
-4.1518
|
-4.0253 | -3.2584 | -8.0402 | -2.6687 |
|
|
3.14%
-4.1518
|
-4.0253 | -3.2584 | -8.0402 | -2.6687 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2.02%
13.64
|
13.37 | 13.17 | 0.0445 | 13.14 |
| Diluted Average Shares |
2.02%
13.64
|
13.37 | 13.17 | 0.0445 | 13.14 |
| Basic Earnings Per Share |
0.00%
-0.30
|
-0.30 | -0.25 | -0.61 | -0.20 |
| Diluted Earnings Per Share |
0.00%
-0.30
|
-0.30 | -0.25 | -0.61 | -0.20 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):